{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:43:18Z","timestamp":1791286998082,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/cgt.2014.32","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T12:56:45Z","timestamp":1403873805000},"page":"317-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Adenovirus expressing \u03b22-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition"],"prefix":"10.1038","volume":"21","author":[{"given":"A B","family":"del Campo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Zinchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ruiz-Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gonz\u00e1lez-Aseguinolaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Aptsiauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,27]]},"reference":[{"key":"BFcgt201432_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0074-7696(07)56005-5","volume":"256","author":"N Aptsiauri","year":"2007","unstructured":"Aptsiauri N, Cabrera T, Garcia-Lora A, Lopez-Nevot MA, Ruiz-Cabello F, Garrido F 2007 MHC class I antigens and immune surveillance in transformed cells. Int Rev Cyto 2007; 256: 139\u2013189.","journal-title":"Int Rev Cyto"},{"key":"BFcgt201432_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/med.20237","volume":"32","author":"R Shashidharamurthy","year":"2011","unstructured":"Shashidharamurthy R, Bozeman EN, Patel J, Kaur R, Meganathan J, Selvaraj P . Immunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development. Med Res Rev 2011; 32: 1197\u20131219.","journal-title":"Med Res Rev"},{"key":"BFcgt201432_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ni0106-7","volume":"7","author":"T Elliott","year":"2006","unstructured":"Elliott T . The \u2018chop-and-change\u2019 of MHC class I assembly. Nat Immunol 2006; 7: 7\u20139.","journal-title":"Nat Immunol"},{"key":"BFcgt201432_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00018-005-5462-z","volume":"63","author":"J Koch","year":"2006","unstructured":"Koch J, Tampe R . The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation. Cell Mol Life Sci 2006; 63: 653\u2013662.","journal-title":"Cell Mol Life Sci"},{"key":"BFcgt201432_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00251-010-0494-4","volume":"63","author":"I Maleno","year":"2011","unstructured":"Maleno I, Aptsiauri N, Cabrera T, Gallego A, Paschen A, Lopez-Nevot MA et al. Frequent loss of heterozygosity in the beta2-microglobulin region of chromosome 15 in primary human tumors. Immunogenetics 2011; 63: 65\u201371.","journal-title":"Immunogenetics"},{"key":"BFcgt201432_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00262-012-1321-6","volume":"61","author":"M Bernal","year":"2012","unstructured":"Bernal M, Ruiz-Cabello F, Concha A, Paschen A, Garrido F . Implication of the b2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol Immunother 2012; 61: 1359\u20131371.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt201432_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","volume":"20","author":"M Challa-Malladi","year":"2011","unstructured":"Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV et al. Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 2011; 20: 728\u2013740.","journal-title":"Cancer Cell"},{"key":"BFcgt201432_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00262-008-0532-3","volume":"57","author":"N Aptsiauri","year":"2008","unstructured":"Aptsiauri N, Carretero R, Garcia-Lora A, Real LM, Cabrera T, Garrido F 2008 Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations. Cancer Immunol Immunother 2008; 57: 1727\u20131733.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt201432_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.25270","volume":"127","author":"F Garrido","year":"2010","unstructured":"Garrido F, Cabrera T, Aptsiauri N . \u2018Hard\u2019 and \u2018soft\u2019 lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy. Int J Cancer 2010; 127: 249\u2013256.","journal-title":"Int J Cancer"},{"key":"BFcgt201432_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1126\/science.3975631","volume":"228","author":"K Tanaka","year":"1985","unstructured":"Tanaka K, Isselbacher KJ, Khoury G, Jay G . Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 1985; 228: 26\u201330.","journal-title":"Science"},{"key":"BFcgt201432_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/315301a0","volume":"315","author":"R Wallich","year":"1985","unstructured":"Wallich R, Bulbuc N, Hammerling GJ, Katzav S, Segal S, Feldman M . Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 1985; 315: 301\u2013305.","journal-title":"Nature"},{"key":"BFcgt201432_CR12","first-page":"23","volume-title":"Gene Delivery Systems: Recent Progress in Viral and Non-Viral Therapy","author":"E Cevher","year":"2012","unstructured":"Cevher E, Sezer A, \u00c7a\u011flar E . Gene delivery systems: recent progress in viral and non-viral therapy. In: Sezer AD (ed.) Gene Delivery Systems: Recent Progress in Viral and Non-Viral Therapy. Intech, Rijeka, Croatia, 2012 pp 23\u201333."},{"key":"BFcgt201432_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jgm.2698","volume":"15","author":"SL Ginn","year":"2013","unstructured":"Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J . Gene therapy clinical trials worldwide to 2012\u2014an update. J Gene Med 2013; 15: 65\u201377.","journal-title":"J Gene Med"},{"key":"BFcgt201432_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/157488509788185123","volume":"4","author":"A Sharma","year":"2009","unstructured":"Sharma A, Tandon M, Bangari DS, Mittal SK . Adenoviral vector-based strategies for cancer therapy. Curr Drug Ther 2009; 4: 117\u2013138.","journal-title":"Curr Drug Ther"},{"key":"BFcgt201432_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri2575","volume":"9","author":"TH Hansen","year":"2009","unstructured":"Hansen TH, Bouvier M . MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 2009; 9: 503\u2013513.","journal-title":"Nat Rev Immunol"},{"key":"BFcgt201432_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2567.2003.01738.x","volume":"110","author":"EW Hewitt","year":"2003","unstructured":"Hewitt EW . The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 2003; 110: 163\u2013169.","journal-title":"Immunology"},{"key":"BFcgt201432_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0065-230X(08)60212-2","volume":"52","author":"S Paabo","year":"1989","unstructured":"Paabo S, Severinsson L, Andersson M, Martens I, Nilsson T, Peterson PA . Adenovirus proteins and MHC expression. Adv Cancer Res 1989; 52: 151\u2013163.","journal-title":"Adv Cancer Res"},{"key":"BFcgt201432_CR18","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.4049\/jimmunol.152.8.3862","volume":"152","author":"DC Beier","year":"1994","unstructured":"Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH . Association of human class I MHC alleles with the adenovirus E3\/19K protein. J Immunol 1994; 152: 3862\u20133872.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/0161-5890(94)90078-7","volume":"31","author":"P Flomenberg","year":"1994","unstructured":"Flomenberg P, Gutierrez E, Hogan KT . Identification of class I MHC regions which bind to the adenovirus E3-19k protein. Mol Immunol 1994; 31: 1277\u20131284.","journal-title":"Mol Immunol"},{"key":"BFcgt201432_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0092-8674(85)90026-1","volume":"43","author":"M Andersson","year":"1985","unstructured":"Andersson M, Paabo S, Nilsson T, Peterson PA . Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 1985; 43: 215\u2013222.","journal-title":"Cell"},{"key":"BFcgt201432_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0092-8674(85)80079-9","volume":"41","author":"HG Burgert","year":"1985","unstructured":"Burgert HG, Kvist S . An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 1985; 41: 987\u2013997.","journal-title":"Cell"},{"key":"BFcgt201432_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2137259","volume":"247","author":"JH Cox","year":"1990","unstructured":"Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR . Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 1990; 247: 715\u2013718.","journal-title":"Science"},{"key":"BFcgt201432_CR23","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1128\/JVI.03391-12","volume":"87","author":"M Sester","year":"2013","unstructured":"Sester M, Ruszics Z, Mackley E, Burgert HG . The transmembrane domain of the adenovirus E3\/19K protein acts as an endoplasmic reticulum retention signal and contributes to intracellular sequestration of major histocompatibility complex class I molecules. J Virol 2013; 87: 6104\u20136117.","journal-title":"J Virol"},{"key":"BFcgt201432_CR24","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.162.9.5049","volume":"162","author":"EM Bennett","year":"1999","unstructured":"Bennett EM, Bennink JR, Yewdell JW, Brodsky FM . Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 1999; 162: 5049\u20135052.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR25","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.4049\/jimmunol.171.9.4473","volume":"171","author":"JL Petersen","year":"2003","unstructured":"Petersen JL, Morris CR, Solheim JC . Virus evasion of MHC class I molecule presentation. J Immunol 2003; 171: 4473\u20134478.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-3083.2009.02276.x","volume":"70","author":"AB del Campo","year":"2009","unstructured":"del Campo AB, Aptsiauri N, Mendez R, Zinchenko S, Vales A, Paschen A et al. Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy. Scand J Immunol 2009; 70: 125\u2013135.","journal-title":"Scand J Immunol"},{"key":"BFcgt201432_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00262-005-0117-3","volume":"55","author":"G Pawelec","year":"2006","unstructured":"Pawelec G, Marsh SG . ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank. Cancer Immunol Immunother 2006; 55: 623\u2013627.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt201432_CR28","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1073\/pnas.93.12.5915","volume":"93","author":"YT Chen","year":"1996","unstructured":"Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ et al. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996; 93: 5915\u20135919.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201432_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ijc.28338","volume":"134","author":"AB del Campo","year":"2014","unstructured":"del Campo AB, Kyte JA, Carretero J, Zinchencko S, Mendez R, Gonzalez-Aseguinolaza G et al. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma. Int J Cancer 2014; 134: 102\u2013113.","journal-title":"Int J Cancer"},{"key":"BFcgt201432_CR30","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1002\/1097-0142(19850515)55:10<2384::AID-CNCR2820551014>3.0.CO;2-3","volume":"55","author":"IP Constantinides","year":"1985","unstructured":"Constantinides IP, Pathouli C, Karvountzis G, Papadopoulos P, Varvoutsi-Constantinides M, Eliakis P et al. Serum beta 2 microglobulin in malignant lymphoproliferative disorders. Cancer 1985; 55: 2384\u20132389.","journal-title":"Cancer"},{"key":"BFcgt201432_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/0961203312447668","volume":"10","author":"ML Hermansen","year":"2012","unstructured":"Hermansen ML, Hummelsh\u00f8j L, Lundsgaard D, Hornum L, Keller P, Fleckner J et al. Increased serum \u03b22-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus 2012; 10: 1098\u20131104.","journal-title":"Lupus"},{"key":"BFcgt201432_CR32","doi-asserted-by":"publisher","first-page":"9108","DOI":"10.1158\/0008-5472.CAN-06-1996","volume":"66","author":"WC Huang","year":"2006","unstructured":"Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M et al. Beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 2006; 66: 9108\u20139116.","journal-title":"Cancer Res"},{"key":"BFcgt201432_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.intimp.2012.03.009","volume":"13","author":"D G\u00fclen","year":"2012","unstructured":"G\u00fclen D, Maas S, Julius H, Warkentin P, Britton H, Younos I et al. Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use. Int Immunopharmacol 2012; 13: 61\u201368.","journal-title":"Int Immunopharmacol"},{"key":"BFcgt201432_CR34","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1073\/pnas.1115050108","volume":"108","author":"DN Vatakis","year":"2011","unstructured":"Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P et al. Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci USA 2011; 108: 1408\u20131416.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201432_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/ijc.20499","volume":"113","author":"JM Romero","year":"2005","unstructured":"Romero JM, Jimenez P, Cabrera T, Cozar JM, Pedrinaci S, Tallada M et al. Coordinated downregulation of the antigen presentation machinery and HLA class I\/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int J Cancer 2005; 113: 605\u2013610.","journal-title":"Int J Cancer"},{"key":"BFcgt201432_CR36","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4049\/jimmunol.174.3.1462","volume":"174","author":"CC Chang","year":"2005","unstructured":"Chang CC, Campoli M, Restifo NP, Wang X, Ferrone S . Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J Immunol 2005; 174: 1462\u20131471.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0198-8859(99)00186-X","volume":"61","author":"DR Johnson","year":"2000","unstructured":"Johnson DR . Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. Hum Immunol 2000; 61: 389\u2013396.","journal-title":"Hum Immunol"},{"key":"BFcgt201432_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1084\/jem.170.3.621","volume":"170","author":"R Versteeg","year":"1989","unstructured":"Versteeg R, Kruse-Wolters KM, Plomp AC, van Leeuwen A, Stam NJ, Ploegh HL et al. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J Exp Med 1989; 170: 621\u2013635.","journal-title":"J Exp Med"},{"key":"BFcgt201432_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00251-010-0470-z","volume":"62","author":"AB Garcia-Ruano","year":"2010","unstructured":"Garcia-Ruano AB, Mendez R, Romero JM, Cabrera T, Ruiz-Cabello F, Garrido F . Analysis of HLA-ABC locus-specific transcription in normal tissues. Immunogenetics 2010; 62: 711\u2013719.","journal-title":"Immunogenetics"},{"key":"BFcgt201432_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s002510000262","volume":"52","author":"M Griffioen","year":"2000","unstructured":"Griffioen M, Ouwerkerk IJ, Harten V, Schrier PI . HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site. Immunogenetics 2000; 52: 121\u2013128.","journal-title":"Immunogenetics"},{"key":"BFcgt201432_CR41","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.4049\/jimmunol.170.4.1894","volume":"170","author":"DR Johnson","year":"2003","unstructured":"Johnson DR . Locus-specific constitutive and cytokine-induced HLA class I gene expression. J Immunol 2003; 170: 1894\u20131902.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR42","doi-asserted-by":"publisher","first-page":"9665","DOI":"10.1073\/pnas.83.24.9665","volume":"83","author":"S Paabo","year":"1986","unstructured":"Paabo S, Nilsson T, Peterson PA . Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 1986; 83: 9665\u20139669.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201432_CR43","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1073\/pnas.82.16.5525","volume":"82","author":"KB Eager","year":"1985","unstructured":"Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appella E et al. Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma. Proc Natl Acad Sci USA 1985; 82: 5525\u20135529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201432_CR44","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1002\/j.1460-2075.1991.tb04995.x","volume":"10","author":"U Nielsch","year":"1991","unstructured":"Nielsch U, Zimmer SG, Babiss LE . Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells. EMBO J 1991; 10: 4169\u20134175.","journal-title":"EMBO J"},{"key":"BFcgt201432_CR45","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1073\/pnas.83.14.5257","volume":"83","author":"R Vasavada","year":"1986","unstructured":"Vasavada R, Eager KB, Barbanti-Brodano G, Caputo A, Ricciardi RP . Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells. Proc Natl Acad Sci USA 1986; 83: 5257\u20135261.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201432_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1074\/jbc.272.1.353","volume":"272","author":"SV Mey-Tal","year":"1997","unstructured":"Mey-Tal SV, Schechter C, Ehrlich R . Synthesis and turnover of beta2-microglobulin in Ad12-transformed cells defective in assembly and transport of class I major histocompatibility complex molecules. J Biol Chem 1997; 272: 353\u2013361.","journal-title":"J Biol Chem"},{"key":"BFcgt201432_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1084\/jem.180.2.477","volume":"180","author":"R Rotem-Yehudar","year":"1994","unstructured":"Rotem-Yehudar R, Winograd S, Sela S, Coligan JE, Ehrlich R . Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J Exp Med 1994; 180: 477\u2013488.","journal-title":"J Exp Med"},{"key":"BFcgt201432_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1084\/jem.183.2.499","volume":"183","author":"R Rotem-Yehudar","year":"1996","unstructured":"Rotem-Yehudar R, Groettrup M, Soza A, Kloetzel PM, Ehrlich R . LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J Exp Med 1996; 183: 499\u2013514.","journal-title":"J Exp Med"},{"key":"BFcgt201432_CR49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1006\/mthe.2002.0570","volume":"5","author":"BM Putzer","year":"2002","unstructured":"Putzer BM, Rodicker F, Hitt MM, Stiewe T, Esche H . Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model. Mol Ther 2002; 5: 405\u2013412.","journal-title":"Mol Ther"},{"key":"BFcgt201432_CR50","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.vaccine.2006.11.064","volume":"25","author":"Y Lou","year":"2007","unstructured":"Lou Y, Seipp RP, Cai B, Chen SS, Vitalis TZ, Choi KB et al. Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1. Vaccine 2007; 25: 2331\u20132339.","journal-title":"Vaccine"},{"key":"BFcgt201432_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijc.21312","volume":"118","author":"B Seliger","year":"2006","unstructured":"Seliger B, Ritz U, Ferrone S . Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer 2006; 118: 129\u2013138.","journal-title":"Int J Cancer"},{"key":"BFcgt201432_CR52","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00262-006-0247-2","volume":"56","author":"JG Gomez-Gutierrez","year":"2007","unstructured":"Gomez-Gutierrez JG, Elpek KG, Montes de Oca-Luna R, Shirwan H, Sam Zhou H, McMasters KM . Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer Immunol Immunother 2007; 56: 997\u20131007.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt201432_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00262-008-0533-2","volume":"58","author":"L Vujanovic","year":"2009","unstructured":"Vujanovic L, Whiteside TL, Potter DM, Chu J, Ferrone S, Butterfield LH . Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus. Cancer Immunol Immunother 2009; 58: 121\u2013133.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt201432_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.molimm.2010.10.017","volume":"48","author":"J Fu","year":"2011","unstructured":"Fu J, Bouvier M . Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules. Mol Immunol 2011; 48: 532\u2013538.","journal-title":"Mol Immunol"},{"key":"BFcgt201432_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1034\/j.1600-0854.2000.010403.x","volume":"1","author":"A Gruhler","year":"2000","unstructured":"Gruhler A, Fruh K . Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones. Traffic 2000; 1: 306\u2013311.","journal-title":"Traffic"},{"key":"BFcgt201432_CR56","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4049\/jimmunol.156.2.700","volume":"156","author":"Y Zhai","year":"1996","unstructured":"Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, Cardoza LM et al. Antigen-specific tumor vaccines: development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J Immunol 1996; 156: 700\u2013710.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0074-7696(05)45004-4","volume":"245","author":"K Bedard","year":"2005","unstructured":"Bedard K, Szabo E, Michalak M, Opas M . Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 2005; 245: 91\u2013121.","journal-title":"Int Rev Cytol"},{"key":"BFcgt201432_CR58","doi-asserted-by":"publisher","first-page":"7646","DOI":"10.4049\/jimmunol.179.11.7646","volume":"179","author":"MW Everett","year":"2007","unstructured":"Everett MW, Edidin M . Tapasin increases efficiency of MHC I assembly in the endoplasmic reticulum but does not affect MHC I stability at the cell surface. J Immunol 2007; 179: 7646\u20137652.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR59","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.1074\/jbc.271.16.9332","volume":"271","author":"L Mery","year":"1996","unstructured":"Mery L, Mesaeli N, Michalak M, Opas M, Lew DP, Krause KH . Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx. J Biol Chem 1996; 271: 9332\u20139339.","journal-title":"J Biol Chem"},{"key":"BFcgt201432_CR60","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ncb1730","volume":"10","author":"E Tasdemir","year":"2008","unstructured":"Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D\u2019Amelio M et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008; 10: 676\u2013687.","journal-title":"Nat Cell Biol"},{"key":"BFcgt201432_CR61","first-page":"781","volume":"55","author":"DR Rowley","year":"1995","unstructured":"Rowley DR, Dang TD, McBride L, Gerdes MJ, Lu B, Larsen M . Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action. Cancer Res 1995; 55: 781\u2013786.","journal-title":"Cancer Res"},{"key":"BFcgt201432_CR62","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.4049\/jimmunol.0802316","volume":"182","author":"A Martayan","year":"2009","unstructured":"Martayan A, Sibilio L, Tremante E, Lo Monaco E, Mulder A, Fruci D et al. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. J Immunol 2009; 182: 3609\u20133617.","journal-title":"J Immunol"},{"key":"BFcgt201432_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/02841869609109926","volume":"35","author":"T Rasmuson","year":"1996","unstructured":"Rasmuson T, Grankvist K, Ljungberg B . Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma. Acta Oncol 1996; 35: 479\u2013482.","journal-title":"Acta Oncol"},{"key":"BFcgt201432_CR64","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1158\/1078-0432.CCR-06-2060","volume":"12","author":"T Nomura","year":"2006","unstructured":"Nomura T, Huang WC, Zhau HE, Wu D, Xie Z, Mimata H et al. Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res 2006; 12: 7294\u20137305.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201432_CR65","doi-asserted-by":"crossref","first-page":"15704","DOI":"10.1016\/S0021-9258(18)82313-4","volume":"268","author":"J Shemesh","year":"1993","unstructured":"Shemesh J, Ehrlich R . Aberrant biosynthesis and transport of class I major histocompatibility complex molecules in cells transformed with highly oncogenic human adenoviruses. J Biol Chem 1993; 268: 15704\u201315711.","journal-title":"J Biol Chem"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201432","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T02:50:09Z","timestamp":1716864609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,27]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFcgt201432"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2014.32","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,27]]},"assertion":[{"value":"12 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}